Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Q3 Revenues Up Amid Narrowed Net Loss

NEW YORK, Nov. 4 (GenomeWeb News) - Cepheid today reported a slight year-over-year increase in third-quarter revenues amid narrowed net losses.


The Sunnyvale, Calif., instrument and reagent company had revenues of $5.4 million for the third quarter, compared to $4.4 million for the third quarter of 2002.  Net loss narrowed to $3.9 million, from $5.8 million for the same period last year.


The company's R&D expenses totaled $4.0 million, compared to $4.5 million in the same period of last year.


As of September 30, Cepheid had $15.2 million in cash and cash equivalents.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.